Weight Loss Maintenance With Once-Weekly Semaglutide 2.4 MG in Adults With Overweight or Obesity Reaching Maintenance Dose (STEP 4)

Background: In people with overweight or obesity, long-term maintenance of weight loss is challenging. Subcutaneous (s.c.) semaglutide, a glucagon-like peptide-1 analogue, has shown clinically-relevant weight loss in a phase 2 trial in people with obesity. STEP 4 investigated the impact of continued...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Endocr Soc
Главные авторы: Rubino, Domenica M, Abrahamsson, Niclas, Davies, Melanie, Hesse, Dan, Greenway, Frank L, Jensen, Camilla, Lingvay, Ildiko, Mosenzon, Ofri, Rosenstock, Julio, Rubio, Miguel A, Rudofsky, Gottfried, Tadayon, Sayeh, Wadden, Thomas A, Dicker, Dror
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2021
Предметы:
Adipose Tissue, Appetite, and Obesity
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089318/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.129
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы